| Prev Close | 6.19 |
| Open | 6.27 |
| Day Low/High | 5.99 / 6.27 |
| 52 Wk Low/High | 4.42 / 18.00 |
| Volume | 231.96K |
Karyopharm Therapeutics, Inc. (KPTI)
6.11
0.08
1.30
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 75.50B |
| Market Cap | 459.78M |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Here's My Biotechnology Shopping List
Biotechnology is always high risk but the right plays move unlike anything else.
Outbreak and Earnings
It is good to be sitting in for Doug Kass on the Daily Diary this Friday. Hopefully we can end the trading week on an up note. It has been a relatively good week for investors, despite a spike in coronavirus cases in China the other day that had equ...
3 Names Making the Case That Investing in Small Biotech Is Never Dull
Karyopharm Therapeutics and Pieris Pharmaceuticals are climbing this week on positive news, while Supernus Pharmaceuticals takes a hit.
2 Attractive Biotechs With Key Study Outcomes on the Horizon
Intra-Cellular Therapies and Acadia Pharmaceuticals are worth investors' attention.
Take a Poker Player's Approach to Playing Small Biotech Stocks
As Kenny Rogers sang, you've got to know when to hold 'em and know when to fold 'em… and sometimes when not to play a hand at all.
Karyopharm Therapeutics Bucks the Downward Trend of the Market
Markets continue to be down across the board as we approach mid-day. Financials are taking it on the chin as trade tensions escalate with China. The financial sector is down 1% on the day but have improved a tad from earlier levels. Despite all the ...
Markets Very Sluggish as August Nears an End
Even concerns about a possible Fed rate hike do not appear to be affecting traders.
